3,964
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Nasal High Flow Use in COPD Patients with Hypercapnic Respiratory Failure: Treatment Algorithm & Review of the Literature

ORCID Icon, , , , , & show all
Pages 101-111 | Received 17 Dec 2019, Accepted 06 Jan 2020, Published online: 22 Jan 2020

References

  • Osadnik CR, Tee VS, Carson-Chahhoud KV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:CD004104. doi:10.1002/14651858.CD004104.pub4.
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019.
  • Ergan B, Oczkowski S, Rochwerg B, et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J. 2019;54(3):1901003. doi:10.1183/13993003.01003-2019.
  • Gay PC. Complications of noninvasive ventilation in acute care. Respir Care. 2009;54(2):246–257.
  • Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device. Eur Respir Rev. 2017;26(145):170028. doi:10.1183/16000617.0028-2017.
  • Spoletini G, Alotaibi M, Blasi F, et al. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications. Chest 2015;148(1):253–261. doi:10.1378/chest.14-2871.
  • Ischaki E, Pantazopoulos I. Blow with the high flow” an updated algorithm. J Emerg Crit Care Med. 2019;3:61–61. doi:10.21037/jeccm.2019.10.03.
  • Pantazopoulos I, Adamos G, Sotiriou A, et al. Nasal high flow application for perioperative support of respiratory system in adult patients. J Emerg Crit Care Med. 2019; doi:10.21037/jeccm.2019.11.02.
  • Fraser JF, Spooner AJ, Dunster KR, et al. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax 2016;71(8):759–761. doi:10.1136/thoraxjnl-2015-207962.
  • Chikata Y, Izawa M, Okuda N, et al. Humidification performance of two high-flow nasal cannula devices: a bench study. Respir Care. 2014;59(8):1186–1190. doi:10.4187/respcare.02932.
  • Pisani L, Vega ML. Use of nasal high flow in stable COPD: rationale and physiology. COPD 2017;14(3):346–350. doi:10.1080/15412555.2017.1315715.
  • Okuda M, Tanaka N, Naito K, et al. Evaluation by various methods of the physiological mechanism of a high-flow nasal cannula (HFNC) in healthy volunteers. BMJ Open Resp Res. 2017;4(1):e000200. doi:10.1136/bmjresp-2017-000200.
  • Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007;20(4):126–131. doi:10.1016/j.aucc.2007.08.001.
  • Bräunlich J, Kohler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077–1085. doi:10.2147/COPD.S104616.
  • Corley A, Caruana LR, Barnett AG, et al. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998–1004. doi:10.1093/bja/aer265.
  • Parke RL, Bloch A, McGuinness SP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care. 2015;60(10):1397–1403. doi:10.4187/respcare.04028.
  • Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–1215. doi:10.1164/rccm.201605-0916OC.
  • Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high-flow oxygen therapy. Respir Care. 2011;56(8):1151–1155. doi:10.4187/respcare.01106.
  • Moller W, Celik G, Feng S, et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol.2015;118(12):1525–1532. doi:10.1152/japplphysiol.00934.2014.
  • Moller W, Feng S, Domanski U, et al. Nasal high flow reduces dead space. J Appl Physiol. 2017;122(1):191–197. doi:10.1152/japplphysiol.00584.2016.
  • Bräunlich J, Mauersberger F, Wirtz H. Effectiveness of nasal high flow in hypercapnic COPD patients is flow and leakage dependent. BMC Pulm Med. 2018;18(1):14. doi:10.1186/s12890-018-0576-x.
  • Hasani A, Chapman TH, McCool D, et al. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis. 2008;5(2):81–86. doi:10.1177/1479972307087190.
  • Fontanari P, Burnet H, Zattara-Hartmann MC, et al. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol.1996;81(4):1739–1743. doi:10.1152/jappl.1996.81.4.1739.
  • Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103(10):1400–1405. doi:10.1016/j.rmed.2009.04.007.
  • Ritchie JE, Williams AB, Gerard C, et al. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography, and measurement of upper airway pressures. Anaesth Intens Care. 2011;39(6):1103–1110. doi:10.1177/0310057X1103900620.
  • Chanques G, Riboulet F, Molinari N, et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol. 2013;79(12):1344–1355.
  • Itagaki T, Okuda N, Tsunano Y, et al. Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients. Respir Care. 2014;59(1):70–74. doi:10.4187/respcare.02480.
  • Vogelsinger H, Halank M, Braun S, et al. Efficacy and safety of nasal high-flow oxygen in COPD patients. BMC Pulm Med. 2017;17(1):143. doi:10.1186/s12890-017-0486-3.
  • Bräunlich J, Seyfarth HJ, Wirtz H. Nasal high-flow versus non-invasive ventilation in stable hypercapnic COPD: a preliminary report. Multidiscip Respir Med. 2015;10(1):27. doi:10.1186/s40248-015-0019-y.
  • Nagata K, Kikuchi T, Horie T, et al. Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease. a multicenter randomized crossover trial. Ann ATS. 2018;15(4):432–439. doi:10.1513/AnnalsATS.201706-425OC.
  • Bräunlich J, Dellweg D, Bastian A, et al. Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD. COPD. 2019;14:1411–1421. doi:10.2147/COPD.S206111.
  • O'Donoghue FJ, Catcheside PG, Jordan AS, et al. Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD. Thorax 2002;57(6):533–539. doi:10.1136/thorax.57.6.533.
  • Pisani L, Fasano L, Corcione N, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax 2017;72(4):373–375. doi:10.1136/thoraxjnl-2016-209673.
  • Miguel-Montanes R, Hajage D, Messika J, et al. Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to moderate hypoxemia. Crit Care Med. 2015;43(3):574–583. doi:10.1097/CCM.0000000000000743.
  • Chatila W, Nugent T, Vance G, et al. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest 2004;126(4):1108–1115. doi:10.1378/chest.126.4.1108.
  • Cirio S, Piran M, Vitacca M, et al. Effects of heated and humidified high flow gases during high-intensity constant-load exercise on severe COPD patients with ventilatory limitation. Respir Med. 2016;118:128–132. doi:10.1016/j.rmed.2016.08.004.
  • Rea H, McAuley S, Jayaram L, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010;104(4):525–533. doi:10.1016/j.rmed.2009.12.016.
  • Ram FS, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004;3:CD004104.
  • Liu J, Duan J, Bai L, et al. Noninvasive ventilation intolerance: characteristics, predictors, and outcomes. Respir Care. 2016;61(3):277–284. doi:10.4187/respcare.04220.
  • Millar J, Lutton S, O’Connor P. The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure. Ther Adv Respir Dis. 2014;8(2):63–64. doi:10.1177/1753465814521890.
  • Pavlov I, Plamondon P, Delisle S. Nasal high-flow therapy for type II respiratory failure in COPD: a report of four cases. Respir Med Case Rep. 2017;20:87–88. doi:10.1016/j.rmcr.2016.12.006.
  • Bräunlich J, Wirtz H. Nasal high-flow in acute hypercapnic exacerbation of COPD. COPD. 2018;13:3895–3897. doi:10.2147/COPD.S185001.
  • Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis. 2018;10(2):882–888. doi:10.21037/jtd.2018.01.125.
  • Yuste ME, Moreno O, Narbona F, et al. Efficacy and safety of high-flow nasal cannula oxygen therapy in moderate acute hypercapnic respiratory failure. Rev Bras Ter Intensiva. 2019;31(2):156–163. doi:10.5935/0103-507X.20190026.
  • Bruni A, Garofalo E, Cammarota G, et al. High flow through nasal cannula in stable and exacerbated chronic obstructive pulmonary disease patients. Rev Recent Clin Trials. 2019;14(4):247–260. doi:10.2174/1574887114666190710180540.
  • Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology 2017;22(6):1149–1155. doi:10.1111/resp.13050.
  • Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J. 2018;12(6):2046–2056. doi:10.1111/crj.12772.
  • Longhini F, Pisani L, Lungu R, et al. High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial. Crit Care Med. 2019;47(6):e506–e511. doi:10.1097/CCM.0000000000003740.
  • Rittayamai N, Phuangchoei P, Tscheikuna J, et al. Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study. Ann Intensive Care. 2019;9(1):122doi:10.1186/s13613-019-0597-5.
  • Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care. 2018;22(1):180. doi:10.1186/s13054-018-2107-9.
  • Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology 2019;25(6):348–354. doi:10.1016/j.pulmoe.2019.08.001.
  • Rzepka-Wrona P, Skoczynski S, Wrona D, et al. Inhalation techniques used in patients with respiratory failure treated with noninvasive mechanical ventilation. Can Respir J. 2018;2018:1–8. doi:10.1155/2018/8959370.
  • Zhou Y, Ahuja A, Irvin CM, et al. Evaluation of nebulizer performance under various humidity conditions. J Aerosol Med. 2005;18(3):283–293. doi:10.1089/jam.2005.18.283.
  • Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med. 2005;172(12):1497–1504. doi:10.1164/rccm.200410-1414OC.
  • Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and nonhumidified circuits during adult mechanical ventilation. Respir Care 2010;55(7):837–844.
  • Michotte JB, Jossen E, Roeseler J, et al. In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses. J Aerosol Med Pulm Drug Deliv. 2014;27(6):430–440. doi:10.1089/jamp.2013.1070.
  • Reminiac F, Vecellio L, Heuze ́-Vourc’h N, et al. Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy. J Aerosol Med Pulm Drug Deliv. 2015;29((2):134–141. doi:10.1089/jamp.2015.1219.
  • Dugernier J, Reychler G, Vecellio L, et al. Nasal high-flow nebulization for lung drug delivery: theoretical, experimental, and clinical application. J Aerosol Med Pulm Drug Deliv. 2019;32(6):341–351.
  • Dailey PA, Harwood R, Walsh K, et al. Aerosol delivery through adult high flow nasal cannula with heliox and oxygen. Respir Care. 2017;62(9):1186–1192. doi:10.4187/respcare.05127.
  • Perry SA, Kesser KC, Geller DE, et al. Influences of cannula size and flow rate on aerosol drug delivery through the vapotherm humidified high-flow nasal cannula system. Pediatr Crit Care Med. 2013;14(5):250–256.
  • Reminiac F, Vecellio L, Loughlin RM, et al. Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study. Pediatr Pulmonol. 2017;52(3):337–344. doi:10.1002/ppul.23509.
  • Bräunlich J, Wirtz H. Oral versus nasal high-flow bronchodilator inhalation in chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv. 2018;31(4):248–254. doi:10.1089/jamp.2017.1432.
  • Reminiac F, Vecellio L, Bodet-Contentin L, et al. Nasal high-flow bronchodilator nebulization: a randomized cross-over study. Ann Intensive Care. 2018;8(1):128. doi:10.1186/s13613-018-0473-8.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
  • Patel A, Nouraei SA. Transnasal humidified rapid insufflation ventilatory exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia 2015;70(3):323–329. doi:10.1111/anae.12923.
  • Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenantion for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med. 2019;45(4):447–458. doi:10.1007/s00134-019-05529-w.
  • Shepard JW, Jr, Burger CD. Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea. Am Rev Respir Dis. 1990;142(6_pt_1):1288e93–1281293. doi:10.1164/ajrccm/142.6_Pt_1.1288.
  • Berg KM, Lang GR, Salciccioli JD, et al. The rapid shallow breathing index as a predictor of failure of noninvasive ventilation for patients with acute respiratory failure. Respir care. 2012;57(10):1548–1554. doi:10.4187/respcare.01597.
  • Nilius G, Franke KJ, Domanski U, et al. Effects of nasal insufflation on arterial gas exchange and breathing pattern in patients with chronic obstructive pulmonary disease and hypercapnic respiratory failure. Adv Exp Med Biol. 2013;755:27–34. doi:10.1007/978-94-007-4546-9_4.
  • Thille AW, Muller G, Gacouin A, et al. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA 2019;322(15):1465. doi:10.1001/jama.2019.14901.
  • Spoletini G, Mega C, Pisani L, et al. High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: a pilot randomized controlled trial. J Crit Care. 2018;48:418–425. doi:10.1016/j.jcrc.2018.10.004.
  • Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med. 2011;37(11):1780–1786. doi:10.1007/s00134-011-2354-6.
  • Kim WY, Sung H, Hong SB, et al. Predictors of high flow nasal cannula failure in immunocompromised patients with acute respiratory failure due to non-HIV pneumocystis pneumonia. J Thorac Dis. 2017;9(9):3013–3022. doi:10.21037/jtd.2017.08.09.
  • Messika J, Ben Ahmed K, Gaudry S, et al. Use of high flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care. 2015;60(2):162–169.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.